Data / New clinical trials / Head and Neck Neoplasms
Head and Neck Neoplasms trials: 341 new since Nov 2024
The full list. New Head and Neck Neoplasms clinical trials: 341 rows for $17.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 18 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/head-and-neck-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
341 clinical studies in Head and Neck Neoplasms were first posted on ClinicalTrials.gov from November 15, 2024 to November 6, 2026; 37 have an industry sponsor and 265 are recruiting or about to. The newest, NCT07922967, was posted on November 6, 2026: Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase... (Oslo University Hospital).
The request: Every new Head and Neck Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 341New trials
- 37Industry sponsored
- 265Recruiting or not yet
- November 6, 2026Latest posted
Newest trials
The newest 100 of 341, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 6, 2026 | NCT07922967 | Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial | Oslo University Hospital | Observational | Recruiting | Head & Neck Cancer | 60 | Norway | clinicaltrials.gov |
| November 6, 2026 | NCT07922759 | Lidocaine Infiltration and Neuroimmunomodulation in Head and Neck Cancer Surgery | University Medical Centre Ljubljana | Phase 4 | Recruiting | Head and Neck Cancer (H&N) | 20 | Slovenia | clinicaltrials.gov |
| November 5, 2026 | NCT07920250 | Pre-Radiotherapy n-6/n-3 Fatty Acid Ratio Predicts Severe Oral Mucositis in Nasopharyngeal Carcinoma | Affiliated Hospital of Guangdong Medical University | Phase 2 | Completed | Nasopharyngeal Carcinoma (NPC), Radiation-induced Oral Mucositis, Head and Neck Neoplasms | 210 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919457 | Phenotype-based Model for Managing Chronic Post-treatment Pain Among Head and Neck Cancer Survivors: a Pilot Study | Shaukat Khanum Memorial Cancer Hospital & Research Centre | Phase 2 | Recruiting | Chronic Postsurgical Pain, Chronic Post Cancer Surgery Pain, Chronic Post Operative Pain, Radiation Effects... | 40 | Pakistan | clinicaltrials.gov |
| November 5, 2026 | NCT07919444 | Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot Study | Shaukat Khanum Memorial Cancer Hospital & Research Centre | Phase 2 | Recruiting | Cancer Pain, Orofacial Pain, Head and Neck Cancer, Head and Neck (HNSCC) | 40 | Pakistan | clinicaltrials.gov |
| November 2, 2026 | NCT07911150 | Gut-Liver-Muscle Axis in Cancer Cachexia | University of Colorado, Denver | Not applicable | Not yet recruiting | Head & Neck Cancer | 20 | United States | clinicaltrials.gov |
| November 2, 2026 | NCT07910799 | Intraoperative Visualization of Large Head and Neck Tumors to Optimize Radiation Therapy Planning Using Liquid Soft-tissue Markers Such as... | University Hospital, Essen | Not applicable | Not yet recruiting | Head & Neck Cancer | 295 | clinicaltrials.gov | |
| November 2, 2026 | NCT07910149 | Airway Ultrasound in Oncologic Maxillofacial Patients | University Hospital Dubrava | Observational | Recruiting | Head and Neck Cancer | 30 | Croatia | clinicaltrials.gov |
| November 2, 2026 | NCT07909603 | Head and Neck Cancer Strategies | Aarhus University Hospital | Observational | Enrolling by invitation | Head and Neck Cancer (H&N), Thyroid Cancer | 1,500 | Denmark | clinicaltrials.gov |
| October 28, 2026 | NCT07901959 | Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia | Rockefeller University | Phase 1 | Recruiting | Fanconi Anemia, Head and Neck Cancer, Squamous Cell Carcinoma, Squamous Cell Cancer of Head and Neck (SCCHN) | 80 | United States | clinicaltrials.gov |
| October 28, 2026 | NCT07899866 | Determinants of Radiation Dermatitis in Head and Neck Cancer Patients Receiving Preventive Photobiomodulation | Hopital Forcilles | Observational | Not yet recruiting | Head and Neck Neoplasms, Radiodermatitis | 150 | France | clinicaltrials.gov |
| October 22, 2026 | NCT07889011 | Effect of Abdominal Massage on Gastrointestinal Symptoms After Head and Neck Cancer Surgery | Maltepe University | Not applicable | Completed | Abdominal Massage, Enteral Nutrition, Nasogastric Feeding, Head and Neck Surgery, Oncology Nursing, Randomized... | 70 | Turkey (Türkiye) | clinicaltrials.gov |
| October 21, 2026 | NCT07887048 | Radiotherapy In a Sitting Position for Enhanced Reproducibility | Centre Leon Berard | Not applicable | Not yet recruiting | Head & Neck Cancer | 16 | clinicaltrials.gov | |
| October 21, 2026 | NCT07885033 | Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy | UNCANCER LLC | Not applicable | Not yet recruiting | Head and Neck Cancer (H&N), Oral Mucositis (Ulcerative) Due to Radiation, Stomatitis (Oral Mucositis), Xerostomia Due... | 50 | United States | clinicaltrials.gov |
| October 20, 2026 | NCT07884487 | Surgical Margin Assessment Using Intra-operative High-resolution PET/CT in Patients With Cancers Referred to Surgical Resection, an... | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Not applicable | Active not recruiting | Breast Cancer, Head and Neck Cancers, Lung Cancer, Sarcoma, Liver Metastases From Colorectal Cancer, Gastro Intestinal... | 250 | Belgium | clinicaltrials.gov |
| October 20, 2026 | NCT07883005 | SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Therapy for Head and Neck Cancer | University Health Network, Toronto | Phase 3 | Not yet recruiting | Head and Neck Cancer | 288 | Canada | clinicaltrials.gov |
| October 20, 2026 | NCT07882888 | Iparomlimab and Tuvonralimab With With Cetuximab in Resectable OSCC | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 | Recruiting | Head and Neck Cancer | 26 | China | clinicaltrials.gov |
| October 14, 2026 | NCT07873450 | SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET | Full-Life Technologies UK Limited | Phase 1/2 | Recruiting | Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer, Cholangiocarcinoma | 208 | Australia, United States | clinicaltrials.gov |
| October 8, 2026 | NCT07866547 | Off-line Adaptive Proton Therapy | University Medical Center Groningen | Observational | Not yet recruiting | Oropharyngeal Carcinoma | 100 | Netherlands | clinicaltrials.gov |
| October 8, 2026 | NCT07865780 | Photobiomodulation Alone Versus Photobiomodulation Combined With Topical Oral Oxygen Therapy for Radiotherapy-Induced Oral Mucositis in... | Assiut University | Phase 1/2 | Enrolling by invitation | Mucositis Oral, Head & Neck Cancer | 46 | Egypt | clinicaltrials.gov |
| October 8, 2026 | NCT07864974 | Predictors of Patient-Reported Outcomes for Maxillectomy Patients | Dr. Merve Benli | Not applicable | Completed | Maxillary Deficiency, Head and Neck Neoplasms | 75 | Turkey (Türkiye) | clinicaltrials.gov |
| October 5, 2026 | NCT07857096 | Rehabilitation Through Individualized Support and Exercise | Universitaire Ziekenhuizen KU Leuven | Not applicable | Not yet recruiting | Oral Cancer, Head and Neck Cancer | 39 | Belgium | clinicaltrials.gov |
| October 5, 2026 | NCT07856732 | Using Silverlon® for Head and Neck Patients With Tracheostomies | State University of New York - Upstate Medical University | Phase 1 | Recruiting | Head and Neck Cancer, Radiation Dermatitis Acute, Radiation Treatment | 10 | United States | clinicaltrials.gov |
| October 5, 2026 | NCT07856719 | A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy | M.D. Anderson Cancer Center | Phase 2 | Not yet recruiting | Head and Neck Cancer | 250 | United States | clinicaltrials.gov |
| October 1, 2026 | NCT07852949 | Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology... | M.D. Anderson Cancer Center | Not applicable | Not yet recruiting | Head and Neck Cancer, Prostate Cancer | 94 | United States | clinicaltrials.gov |
| October 1, 2026 | NCT07851857 | Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial) | AC Camargo Cancer Center | Phase 3 | Recruiting | Surgical Wound Infection, Head and Neck Neoplasms, Oral Cancer Neoplasms, Pharyngeal Neoplasms | 80 | Brazil | clinicaltrials.gov |
| October 1, 2026 | NCT07851818 | Screening Psychosocial Distress in Head and Neck Cancer | Hôpital NOVO | Observational | Not yet recruiting | Head and Neck Cancer (H&N) | 80 | clinicaltrials.gov | |
| September 30, 2026 | NCT07848841 | Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery | Washington University School of Medicine | Not applicable | Recruiting | Head and Neck Cancer (H&N), Cancer of the Head and Neck | 50 | United States | clinicaltrials.gov |
| September 29, 2026 | NCT07848061 | A Master Regulator of Lipid-Associated Macrophage Function in Cancer | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Breast Cancer, Head & Neck Cancer | 120 | Italy | clinicaltrials.gov |
| September 29, 2026 | NCT07847060 | Hypofractionated Radiotherapy in Older Adults With Head and Neck Squamous Cell Carcinoma | Assiut University | Not applicable | Not yet recruiting | Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Head and Neck Neoplasms | 60 | clinicaltrials.gov | |
| September 25, 2026 | NCT07840456 | Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial | University Hospital, Basel, Switzerland | Phase 2 | Not yet recruiting | Carcinoma, Squamous Cell of Head and Neck HNSCC | 66 | Germany, Switzerland | clinicaltrials.gov |
| September 24, 2026 | NCT07838857 | Evaluation of Adherence to Rehabilitation: Autonomous and Guided, in the Observation and Treatment Response of Head and Neck Lymphedema in... | Hopital Forcilles | Not applicable | Not yet recruiting | Lymphedema, Head and Neck Neoplasms | 56 | clinicaltrials.gov | |
| September 24, 2026 | NCT07838090 | Resistance Training and Creatine Supplementation for Head and Neck Cancer | Medical University of South Carolina | Not applicable | Not yet recruiting | Head and Neck Cancer, Cancer Survivorship, Treatment-related Muscle Loss, Physical Function | 30 | United States | clinicaltrials.gov |
| September 16, 2026 | NCT07823309 | Quad Shot Versus Split Course Radiotherapy in Incurable Head and Neck Cancer | Instituto Nacional de Cancerologia, Columbia | Not applicable | Not yet recruiting | Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck | 40 | clinicaltrials.gov | |
| September 16, 2026 | NCT07823283 | Continuous Monitoring of Microvascular Anastomoses: An Observational Trial | Mayo Clinic | Observational | Recruiting | Head and Neck Neoplasm | 100 | United States | clinicaltrials.gov |
| September 16, 2026 | NCT07822815 | Difficult Airway Management in Oncology: An International Delphi Consensus Study (DAMO) | Onco Critical Care Society | Observational | Enrolling by invitation | Neoplasms, Airway Obstruction Upper, Intubation, Intratracheal, Head and Neck Neoplasms, Mediastinal Neoplasms, Airway... | 40 | India | clinicaltrials.gov |
| September 15, 2026 | NCT07821242 | Nimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | Ke Hu | Phase 2 | Not yet recruiting | Head & Neck Cancer, Radiotherapy | 46 | China | clinicaltrials.gov |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | United States | clinicaltrials.gov |
| September 10, 2026 | NCT07814248 | A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a... | TwoStep Therapeutics, Inc. | Phase 1 | Recruiting | NSCLC (Non-small Cell Lung Cancer), HNSCC, Endometrial, Ovarian Cancer, Esophageal Cancer, Head & Neck Cancer, Gastric... | 74 | United States | clinicaltrials.gov |
| September 10, 2026 | NCT07813923 | Citrus Sinensis Peel Gel for Radiation-Induced Oral Mucositis | Alexandria University | Not applicable | Not yet recruiting | Radiation-induced Oral Mucositis, Head and Neck Cancer | 30 | Egypt | clinicaltrials.gov |
| September 9, 2026 | NCT07809776 | Tai Chi for Cancer-Related Fatigue During Radiotherapy in Patients With Head and Neck Cancer | West China Hospital | Not applicable | Recruiting | Head and Neck Neoplasms, Cancer-related Fatigue | 116 | China | clinicaltrials.gov |
| September 8, 2026 | NCT07807163 | A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC | Bicara Therapeutics | Phase 2 | Recruiting | Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | 160 | United States | clinicaltrials.gov |
| September 3, 2026 | NCT07802977 | Intraparenchymal Salivary Gland Corticosteroid Injection to Prevent Radiation-Induced Xerostomia | University of California, Davis | Phase 1 | Completed | Xerostomia, Head and Neck Squamous Cell Carcinoma | 10 | United States | clinicaltrials.gov |
| September 1, 2026 | NCT07798414 | Randomized Clinical Trial of the Application of TrachPhone HME and the Impact on Patient Satisfaction for Tracheostomized Head and Neck... | University of South Florida | Phase 1/2 | Not yet recruiting | Patient Satisfaction, Pulmonary Rehabilitation | 80 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07796126 | Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer (HNSCC) and Poor Performance Status | Barbara Ann Karmanos Cancer Institute | Phase 2 | Not yet recruiting | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | 22 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07795294 | Swallowing Rehabilitation Program for Head and Neck Tumor Patients | Delta University for Science and Technology | Not applicable | Recruiting | Head and Neck Cancer (H&N) | 80 | Egypt | clinicaltrials.gov |
| August 31, 2026 | NCT07795034 | To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for... | Neuboron Bio-SciTech Co., Ltd. | Phase 2 | Recruiting | Head and Neck Cancer | 35 | China | clinicaltrials.gov |
| August 28, 2026 | NCT07791602 | Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Active not recruiting | Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Cancer, HNSCC | 180 | China | clinicaltrials.gov |
| August 24, 2026 | NCT07780877 | Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer | Fudan University | Phase 2 | Not yet recruiting | Head & Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma | 85 | China | clinicaltrials.gov |
| August 21, 2026 | NCT07778290 | Topical Boswellia Serrata 2% to Prevent Radiation Dermatitis in Head and Neck Cancer | Youssef Hashem Hafez | Not applicable | Recruiting | Head and Neck Neoplasms, Radiodermatitis | 60 | Egypt | clinicaltrials.gov |
| August 19, 2026 | NCT07772063 | Immunomonitoring of Circulating Immune Cells in Maxillofacial Surgery | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Head and Neck Cancer (H&N), Trauma Sequelae, Osteoradionecrosis of Jaws | 60 | clinicaltrials.gov | |
| August 18, 2026 | NCT07770100 | Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) | Mark Bernard | Phase 2 | Recruiting | Head and Neck Cancer, Non-Small Cell Lung Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer (GC) | 35 | United States | clinicaltrials.gov |
| August 17, 2026 | NCT07766889 | Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma | Sun Yat-sen University | Phase 2 | Not yet recruiting | Oral Squamous Cell Carcinoma, Head and Neck Cancer, Locally Advanced Head and Neck Cancer, Neoadjuvant Therapy | 32 | China | clinicaltrials.gov |
| August 13, 2026 | NCT07763639 | A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 1 | Recruiting | Head and Neck Tumors, Solid Tumors | 30 | China | clinicaltrials.gov |
| August 12, 2026 | NCT07759193 | Energy Expenditure Assessment in Head and Neck Cancer Patients Treated With Free Flap Surgery | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | Reconstructive Surgical Procedures, Free Tissue Flaps, Head and Neck Cancer, Perioperative Care | 19 | Israel | clinicaltrials.gov |
| August 11, 2026 | NCT07756684 | Feasibility of Cough Skill Training in Individuals With Head and Neck Cancer | Boston University Charles River Campus | Not applicable | Recruiting | Head and Neck Cancers | 10 | United States | clinicaltrials.gov |
| August 10, 2026 | NCT07755449 | CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation) | Institut Català d'Oncologia | Phase 2 | Recruiting | Locally Advanced Head and Neck Squamous Cell Carcinoma | 101 | Spain | clinicaltrials.gov |
| August 7, 2026 | NCT07752875 | A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation | LG Chem | Phase 1/2 | Not yet recruiting | Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Esophageal Cancer, Breast... | 250 | clinicaltrials.gov | |
| August 7, 2026 | NCT07752394 | Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma | Tang-Du Hospital | Phase 2 | Not yet recruiting | Head & Neck Cancer | 15 | China | clinicaltrials.gov |
| August 3, 2026 | NCT07741643 | Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head... | Vanderbilt-Ingram Cancer Center | Phase 1 | Recruiting | HNSCC,Larynx, Pharynx and Oral Cavity, Squamous Cell Carcinoma, Head and Neck Cancer, Head and Neck Surgery | 30 | United States | clinicaltrials.gov |
| August 3, 2026 | NCT07741565 | Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC) | Vanderbilt-Ingram Cancer Center | Early phase 1 | Recruiting | HNSCC, SCC - Squamous Cell Carcinoma, Oral Cancer | 18 | United States | clinicaltrials.gov |
| August 3, 2026 | NCT07741435 | Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | Observational | Recruiting | Neoplasms, Solid Tumor, Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms, Uterine Cervical Neoplasms, Colorectal... | 3,250 | Colombia | clinicaltrials.gov |
| July 31, 2026 | NCT07740616 | Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer Survivors | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Head and Neck Cancer (H&N) | 30 | United States | clinicaltrials.gov |
| July 29, 2026 | NCT07732686 | Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | University of Oklahoma | Observational | Not yet recruiting | Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon... | 2,000 | United States | clinicaltrials.gov |
| July 29, 2026 | NCT07732634 | RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable... | University of Illinois Chicago | Phase 2 | Not yet recruiting | Head and Neck Cancer, Head Cancer, Neck Cancer | 20 | United States | clinicaltrials.gov |
| July 24, 2026 | NCT07726407 | SGRT in Head and Neck Cancer Radiotherapy | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Recruiting | Head and Neck Cancer, Radiotherapy, Conformal (IMRT) | 40 | China | clinicaltrials.gov |
| July 24, 2026 | NCT07726199 | Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread | Kolhapur Cancer Centre - Cancer Centers of America | Not applicable | Recruiting | Oral Squamous Cell Carcinoma (OSCC) | 267 | India | clinicaltrials.gov |
| July 23, 2026 | NCT07723495 | Symptom Management to Improve Completion of Patient-reported Outcome Measures | Henry Ford Health System | Not applicable | Not yet recruiting | Malignant Solid Neoplasm, Malignant Head and Neck Neoplasm, Malignant Lung Neoplasm | 78 | United States | clinicaltrials.gov |
| July 22, 2026 | NCT07718620 | HPV-associated Oropharyngeal Carcinoma (HPV-OPC) | Masaryk Memorial Cancer Institute | Not applicable | Recruiting | Oropharyngeal Carcinoma (OPC) | 35 | Czechia | clinicaltrials.gov |
| July 21, 2026 | NCT07717307 | Study Comparing Limited and Extensive Neck Surgery in Oral Cancer Patients With Neck Spread | Kolhapur Cancer Centre - Cancer Centers of America | Not applicable | Recruiting | Oral Cavity Squamous Cell Carcinoma | 80 | India | clinicaltrials.gov |
| July 17, 2026 | NCT07712120 | Brief Clinical Psychological Intervention With Biofeedback in Head and Neck Cancer | University of Turin, Italy | Not applicable | Recruiting | Head and Neck Cancer, Surgery for Head and Neck Cancer Patients, Demolitive Surgical Procedures on the Oral Cavity or... | 58 | Italy | clinicaltrials.gov |
| July 17, 2026 | NCT07711626 | Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT | Tzu Chi University | Not applicable | Recruiting | Head and Neck Neoplasms, Xerostomia, Cancer-related Fatigue, Pain | 180 | Taiwan | clinicaltrials.gov |
| July 15, 2026 | NCT07705074 | FAPI PET Imaging - An Exploratory Study | Martin Huellner | Phase 1/2 | Not yet recruiting | Thyroid Pathology, Head and Neck Cancer (H&N), Sinonasal Tract Tumor, Sarcoidosis, Thyroid Cancer, Breast Cancer... | 770 | Switzerland | clinicaltrials.gov |
| July 15, 2026 | NCT07704372 | Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer | West China Hospital | Phase 2 | Recruiting | Radiation-induced Dermatitis | 140 | China | clinicaltrials.gov |
| July 13, 2026 | NCT07697287 | Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment | McMaster University | Phase 4 | Active not recruiting | Squamous Cell Carcinoma, Oropharyngeal Cancers, Nasopharyngeal Cancer, Hypopharyngeal Cancer | 29 | Canada | clinicaltrials.gov |
| July 10, 2026 | NCT07694726 | Preventing Lymphedema in Patients Undergoing Surgical Treatment for Head and Neck Cancer Through Vein Reconstruction | University of Pittsburgh | Not applicable | Recruiting | Head and Neck Cancer | 37 | United States | clinicaltrials.gov |
| July 9, 2026 | NCT07692997 | Sancai Fengsui Decoction for RTOM: A Multicenter RCT | Nanfang Hospital, Southern Medical University | Phase 2 | Not yet recruiting | Radiation-Induced Oral Mucositis (RTOM), Head and Neck Cancer, Oral Mucositis of RTOG Grade Greater Than 1 | 126 | clinicaltrials.gov | |
| July 8, 2026 | NCT07690917 | A Study of a New PET Scanner in People With Cancer | Memorial Sloan Kettering Cancer Center | Observational | Recruiting | Non Small Cell Lung Carcinoma NSCLC, Head and Neck Cancer, Prostate Cancer | 90 | United States | clinicaltrials.gov |
| July 8, 2026 | NCT07690631 | Impact of Chronic MICROplastic Exposure on RADiotherapy of Head and Neck Cancer Patients: Clinical and Translational Oncology Study: | University of Kragujevac | Observational | Not yet recruiting | Head and Neck Cancer, Microplastic Exposure | 500 | clinicaltrials.gov | |
| July 8, 2026 | NCT07690618 | Thermotherapy for Head and Neck Cancer Patients | Erasmus Medical Center | Phase 1 | Recruiting | Head and Neck Cancer, Oropharyngeal Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma, Head and Neck Squamous... | 30 | Netherlands | clinicaltrials.gov |
| July 7, 2026 | NCT07689019 | Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short Term Prognosis of Head and Neck Cancer Patients... | Buddhist Tzu Chi General Hospital | Not applicable | Recruiting | Head and Neck Cancer (H&N) | 102 | Taiwan | clinicaltrials.gov |
| June 30, 2026 | NCT07676461 | Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer (H&N) | 150 | Colombia | clinicaltrials.gov |
| June 30, 2026 | NCT07675967 | Clonal Hematopoiesis Chemotherapy and Radiation Effects Study | Dana-Farber Cancer Institute | Observational | Recruiting | Lung Cancer (Diagnosis), Osteochondroma, Spitz Nevus, Solid Cancers, Breast Cancer, Gastric (Stomach) Cancer... | 5,000 | United States | clinicaltrials.gov |
| June 30, 2026 | NCT07675421 | Impact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer | Federal University of Minas Gerais | Not applicable | Recruiting | Head and Neck Cancers | 66 | Brazil | clinicaltrials.gov |
| June 29, 2026 | NCT07674706 | Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers | National University Hospital, Singapore | Not applicable | Not yet recruiting | Xerostomia, Head Cancer, Neck Cancer, Nasopharyngeal Carcinoma (NPC), Oral Cavity Squamous Cell Carcinoma... | 50 | Singapore | clinicaltrials.gov |
| June 29, 2026 | NCT07672912 | Ultrasound-Guided Hook-Wire Localization for Excision of Non-palpable Cervical Lesions Suspicious for Metastasis | Rusana Bark | Not applicable | Completed | Non Palpable Cervical Lesions Suspicious for Metastasis | 50 | Sweden | clinicaltrials.gov |
| June 26, 2026 | NCT07672236 | A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer. | OncoZenge AB | Phase 3 | Recruiting | Head & Neck Cancer, Oral Mucositis | 150 | Denmark, Germany, Norway, Sweden | clinicaltrials.gov |
| June 26, 2026 | NCT07671573 | Integrated Early-CARE for Head & Neck Cancer. | Portuguese Oncology Institute, Coimbra | Not applicable | Not yet recruiting | Head & Neck Cancer, Locally Advanced Head and Neck Cancer, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | 64 | Portugal | clinicaltrials.gov |
| June 26, 2026 | NCT07670403 | Digital Phenotyping of Psychological Distress in Skin Cancer Patients | West China Hospital | Observational | Withdrawn | Skin Cancer, Melanoma (Skin Cancer), Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Basal Cell Carcinoma of Skin | 0 | China | clinicaltrials.gov |
| June 25, 2026 | NCT07667400 | Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer | National Cancer Institute (NCI) | Phase 1/2 | Recruiting | Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Paranasal Sinus Neoplasms, Nasopharyngeal Carcinoma... | 120 | United States | clinicaltrials.gov |
| June 25, 2026 | NCT07667296 | APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma | Aveta Biomics, Inc. | Phase 3 | Not yet recruiting | Head and Neck Cancer, Head and Neck (HNSCC), Oropharyngeal, Oral Cavity, Oral Cavity Carcinoma, Oropharynx Squamous... | 826 | clinicaltrials.gov | |
| June 24, 2026 | NCT07664241 | Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial | OHSU Knight Cancer Institute | Not applicable | Not yet recruiting | Malignant Head and Neck Neoplasm | 56 | United States | clinicaltrials.gov |
| June 23, 2026 | NCT07662746 | Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 | Recruiting | Head and Neck Cancer | 29 | China | clinicaltrials.gov |
| June 23, 2026 | NCT07662681 | Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 1/2 | Recruiting | Head and Neck Cancer | 40 | China | clinicaltrials.gov |
| June 22, 2026 | NCT07659678 | CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma | Washington University School of Medicine | Phase 2 | Recruiting | Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Head... | 90 | United States | clinicaltrials.gov |
| June 16, 2026 | NCT07651020 | The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Completed | Pancreatic Cancer, Breast Cancer, Lung Cancer, Sarcoma, Head and Neck Cancers, Glioblastoma, Colorectal Cancer... | 1 | China | clinicaltrials.gov |
| June 12, 2026 | NCT07644585 | A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck | IBA Proton Therapy, Inc. | Not applicable | Recruiting | Head and Neck Cancer | 10 | United States | clinicaltrials.gov |
| June 10, 2026 | NCT07639970 | Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors | Hua Pang | Early phase 1 | Not yet recruiting | Breast Cancer, Head and Neck Cancer (H&N), Pancreatic Cancer, Glioma | 20 | clinicaltrials.gov | |
| June 9, 2026 | NCT07635641 | REPROton-HN: Prospective Observational Study on Proton Re-irradiation for Locoregional Recurrences of Head and Neck Tumors | Istituto Clinico Humanitas | Observational | Recruiting | Head & Neck Cancer | 50 | Italy | clinicaltrials.gov |
| June 9, 2026 | NCT07635420 | Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical Assessment for Flap Perfusion in Head and Neck... | Region Skane | Phase 4 | Recruiting | Head and Neck Cancer (H&N), Free Tissue Flaps, Free Flap, Free Flap Evaluation, Indocyanine Green, Indocyanine Green... | 244 | Sweden | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| West China Hospital | 13 | September 9, 2026 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 6 | October 20, 2026 |
| Vanderbilt-Ingram Cancer Center | 5 | August 3, 2026 |
| Ain Shams University | 5 | February 6, 2026 |
| M.D. Anderson Cancer Center | 4 | October 5, 2026 |
| Washington University School of Medicine | 4 | September 30, 2026 |
| Nanfang Hospital, Southern Medical University | 4 | July 9, 2026 |
| Chang Gung Memorial Hospital | 4 | February 9, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 | September 29, 2026 |
| Medical University of South Carolina | 3 | September 24, 2026 |
| Mayo Clinic | 3 | September 16, 2026 |
| Sun Yat-sen University | 3 | August 17, 2026 |
| Tang-Du Hospital | 3 | August 7, 2026 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 3 | July 24, 2026 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 | June 16, 2026 |
| UNC Lineberger Comprehensive Cancer Center | 3 | June 5, 2026 |
| University of Pavia | 3 | March 24, 2026 |
| Institute of Oncology Ljubljana | 3 | February 24, 2026 |
| Peter MacCallum Cancer Centre, Australia | 3 | February 4, 2026 |
| Cairo University | 3 | December 31, 2025 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 110 | November 2, 2026 |
| Observational | 81 | November 6, 2026 |
| Phase 2 | 66 | November 5, 2026 |
| Phase 1 | 30 | October 28, 2026 |
| Phase 1/2 | 19 | October 14, 2026 |
| Phase 3 | 14 | October 20, 2026 |
| Phase 4 | 8 | November 6, 2026 |
| Early phase 1 | 7 | August 3, 2026 |
| Phase 2/3 | 6 | May 7, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 102 | November 2, 2026 |
| China | 57 | November 5, 2026 |
| Italy | 23 | September 29, 2026 |
| France | 18 | October 28, 2026 |
| Taiwan | 17 | July 17, 2026 |
| Egypt | 14 | October 8, 2026 |
| Belgium | 8 | October 20, 2026 |
| Canada | 8 | October 20, 2026 |
| Australia | 8 | October 14, 2026 |
| Germany | 8 | September 25, 2026 |
| Turkey (Türkiye) | 7 | October 22, 2026 |
| Netherlands | 7 | October 8, 2026 |
| India | 7 | September 16, 2026 |
| Sweden | 6 | June 29, 2026 |
| Switzerland | 5 | September 25, 2026 |
| Spain | 5 | August 10, 2026 |
| United Kingdom | 5 | May 29, 2026 |
| South Korea | 5 | March 10, 2026 |
| Slovenia | 4 | November 6, 2026 |
| Denmark | 4 | November 2, 2026 |
| Brazil | 4 | October 1, 2026 |
| Norway | 2 | November 6, 2026 |
| Pakistan | 2 | November 5, 2026 |
| Israel | 2 | August 12, 2026 |
| Colombia | 2 | August 3, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.